GLENMARK PHARMACEUTICALS LTD. - Outcome of Operations Committee Meeting

Glenmark Pharmaceuticals Ltd has informed BSE that the Operations Committee of the Board of Directors of the Company, at its Meeting held on June 16, 2015, allotted 17,803 Equity Shares of the face value of Re. 1/- each in the ratio of Four (4) Equity Shares of Re. 1 each of Glenmark Pharmaceuticals Limited for every Five (5) Equity Shares of Rs. 10/- each held of Glenmark Generics Limited pursuant to Scheme of Amalgamation of Glenmark Generics Limited with Glenmark Pharmaceuticals Limited approved by Hon'ble High Court of Bombay.